Marijn de Bruin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marijn de Bruin has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Harm J. Hospers
3 shared publications- Ramsey A. Lyimo
Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, P.O.Box 2236, Moshi, Tanzania
3 shared publications - Andre van der Ven
Department of General Internal Medicine, Nijmegen Institute for International Health (456)
2 shared publications - Declare Mushi
Community Health Department, Kilimanjaro Christian Medical College, P.O.Box 2240, Moshi, Tanzania
2 shared publications Gerjo Kok
2 shared publications- Harm J. Hospers
University College Maastricht, Maastricht University, Maastricht, The Netherlands
2 shared publications
Latest Publications
- 1 January 2017
- Published by American Psychological Association (APA)
Planned Behaviour Model Survey
- Open Access
- 14 September 2012
- Published by Springer Nature in Implementation Science
- Vol. 7 (1) , 92
A systematic review of hand hygiene improvement strategies: a behavioural approach
Many strategies have been designed and evaluated to address the problem of low hand hygiene (HH) compliance. Which of these strategies are most effective and how they work is still unclear. Here we describe frequently used improvement strategies and related determinants of behaviour change that prompt good HH behaviour to provide a better overview of the choice and content of such strategies.
- 14 September 2012
- Published by Springer Nature in Implementation Science
- Vol. 7 (1) , 92
Open AccessA systematic review of hand hygiene improvement strategies: a behavioural approach
Many strategies have been designed and evaluated to address the problem of low hand hygiene (HH) compliance. Which of these strategies are most effective and how they work is still unclear. Here we describe frequently used improvement strategies and related determinants of behaviour change that prompt good HH behaviour to provide a better overview of the choice and content of such strategies.
- Open Access
- 31 August 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e44029
The Meaning of Adherence When Behavioral Risk Patterns Vary: Obscured Use- and Method-Effectiveness in HIV-Prevention Trials
Recently promising trials of innovative biomedical approaches to prevent HIV transmission have been reported. Participants' non-adherence to the prevention methods complicates the analyses and interpretation of trial results. The influence of variable sexual behaviors within and between participants of trials further obscures matters. Current methodological and statistical approaches in HIV-prevention studies, as well as ongoing debates on contradictory trial results, may fail to accurately address these topics. Through developing a cumulative probability model of infection within HIV prevention trials, we demonstrate how adherence and sexual behavior patterns impact the overall estimate of effectiveness, the effectiveness of prevention methods as a function of adherence, and conclusions about methods' true effectiveness. Applying the model to summary-level data from the CAPRISA trial, we observe markedly different values for the true method effectiveness of the microbicide, and show that if the gel would have been tested among women with slightly different sexual behavior patterns, conclusions might well have been that the gel is not effective. Relative risk and adherence analyses in HIV prevention trials overlook the complex interplay between adherence and sexual behavior patterns. Consequently, they may not provide accurate estimates of use- and method-effectiveness. Moreover, trial conclusions are contingent upon the predominant sexual behavior pattern of participants and cannot be directly generalized to other contexts. We recommend researchers to (re)examine their data and use the cumulative probability model to estimate the true method effectiveness, which might contribute to resolving current questions about contradictory trial results. Moreover, we suggest taking into account the issues raised in the design of future trials and in population models estimating the impact of large-scale dissemination of prevention methods. Comprehension of the topics described will help readers to better interpret (apparently contradictory) trial outcomes.
- 31 August 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e44029
Open AccessThe Meaning of Adherence When Behavioral Risk Patterns Vary: Obscured Use- and Method-Effectiveness in HIV-Prevention Trials
Recently promising trials of innovative biomedical approaches to prevent HIV transmission have been reported. Participants' non-adherence to the prevention methods complicates the analyses and interpretation of trial results. The influence of variable sexual behaviors within and between participants of trials further obscures matters. Current methodological and statistical approaches in HIV-prevention studies, as well as ongoing debates on contradictory trial results, may fail to accurately address these topics. Through developing a cumulative probability model of infection within HIV prevention trials, we demonstrate how adherence and sexual behavior patterns impact the overall estimate of effectiveness, the effectiveness of prevention methods as a function of adherence, and conclusions about methods' true effectiveness. Applying the model to summary-level data from the CAPRISA trial, we observe markedly different values for the true method effectiveness of the microbicide, and show that if the gel would have been tested among women with slightly different sexual behavior patterns, conclusions might well have been that the gel is not effective. Relative risk and adherence analyses in HIV prevention trials overlook the complex interplay between adherence and sexual behavior patterns. Consequently, they may not provide accurate estimates of use- and method-effectiveness. Moreover, trial conclusions are contingent upon the predominant sexual behavior pattern of participants and cannot be directly generalized to other contexts. We recommend researchers to (re)examine their data and use the cumulative probability model to estimate the true method effectiveness, which might contribute to resolving current questions about contradictory trial results. Moreover, we suggest taking into account the issues raised in the design of future trials and in population models estimating the impact of large-scale dissemination of prevention methods. Comprehension of the topics described will help readers to better interpret (apparently contradictory) trial outcomes.
- Open Access
- 30 August 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 716
Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective
To design effective, tailored interventions to support antiretroviral therapy (ART) adherence, a thorough understanding of the barriers and facilitators of ART adherence is required. Factors at the individual and interpersonal level, ART treatment characteristics and health care factors have been proposed as important adherence determinants.
- 30 August 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 716
Open AccessDeterminants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective
To design effective, tailored interventions to support antiretroviral therapy (ART) adherence, a thorough understanding of the barriers and facilitators of ART adherence is required. Factors at the individual and interpersonal level, ART treatment characteristics and health care factors have been proposed as important adherence determinants.
- Open Access
- 13 October 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 798
Stressors and resources mediate the association of socioeconomic position with health behaviours
Variability in health behaviours is an important cause of socioeconomic health disparities. Socioeconomic differences in health behaviours are poorly understood. Previous studies have examined whether (single) stressors or psychosocial resources mediate the relationship between socioeconomic position and health or mortality. This study examined: 1) whether the presence of stressors and the absence of resources can be represented by a single underlying factor, and co-occur among those with lower education, 2) whether stressors and resources mediated the relation between education and health behaviours, and 3) addressed the question whether an aggregate measure of stressors and resources has an added effect over the use of individual measures.
- 13 October 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 798
Open AccessStressors and resources mediate the association of socioeconomic position with health behaviours
Variability in health behaviours is an important cause of socioeconomic health disparities. Socioeconomic differences in health behaviours are poorly understood. Previous studies have examined whether (single) stressors or psychosocial resources mediate the relationship between socioeconomic position and health or mortality. This study examined: 1) whether the presence of stressors and the absence of resources can be represented by a single underlying factor, and co-occur among those with lower education, 2) whether stressors and resources mediated the relation between education and health behaviours, and 3) addressed the question whether an aggregate measure of stressors and resources has an added effect over the use of individual measures.
- Open Access
- 9 February 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 92
Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System
An often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.
- 9 February 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 92
Open AccessMeasuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System
An often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.
- Open Access
- 8 February 2010
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 170 (3) , 240-250
Standard Care Impact on Effects of Highly Active Antiretroviral Therapy Adherence Interventions
Human immunodeficiency virus (HIV) can be effectively suppressed with highly active antiretroviral therapy (HAART), but approximately 50% of patients do not achieve and sustain the high levels of medication adherence required for optimal viral suppression (ie, 90%-95%).1-4 Numerous adherence-supporting interventions have been developed and evaluated, and systematic reviews and meta-analyses have synthesized these studies up to 2006.5-8 While several interventions have been found to be effective, reviews have not clarified why some interventions are more effective than others. Hence, guidance for improvement of care is limited.
- 8 February 2010
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 170 (3) , 240-250
Open AccessStandard Care Impact on Effects of Highly Active Antiretroviral Therapy Adherence Interventions
Human immunodeficiency virus (HIV) can be effectively suppressed with highly active antiretroviral therapy (HAART), but approximately 50% of patients do not achieve and sustain the high levels of medication adherence required for optimal viral suppression (ie, 90%-95%).1-4 Numerous adherence-supporting interventions have been developed and evaluated, and systematic reviews and meta-analyses have synthesized these studies up to 2006.5-8 While several interventions have been found to be effective, reviews have not clarified why some interventions are more effective than others. Hence, guidance for improvement of care is limited.
- 1 January 2009
- Published by American Psychological Association (APA) in Health Psychology
- Vol. 28 (6) , 668-674
Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: Implications for the interpretation and comparison of intervention effects.
Clinical trials of behavioral interventions seek to enhance evidence-based health care. However, in case the quality of standard care provided to control conditions varies between studies and affects outcomes, intervention effects cannot be directly interpreted or compared. The objective of the present study was to examine whether standard care quality (SCQ) could be reliably assessed, varies between studies of highly active antiretroviral HIV-adherence interventions, and is related to the proportion of patients achieving an undetectable viral load ("success rate"). Databases were searched for relevant articles. Authors of selected studies retrospectively completed a checklist with standard care activities, which were coded to compute SCQ scores. The relationship between SCQ and the success rates was examined using meta-regression. Cronbach's alpha, variability in SCQ, and relation between SCQ and success rate. Reliability of the SCQ instrument was high (Cronbach's alpha = .91). SCQ scores ranged from 3.7 to 27.8 (total range = 0-30) and were highly predictive of success rate (p = .002). Variation in SCQ provided to control groups may substantially influence effect sizes of behavior change interventions. Future trials should therefore assess and report SCQ, and meta-analyses should control for variability in SCQ, thereby producing more accurate estimates of the effectiveness of behavior change interventions.
- 1 January 2009
- Published by American Psychological Association (APA) in Health Psychology
- Vol. 28 (6) , 668-674
Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: Implications for the interpretation and comparison of intervention effects.
Clinical trials of behavioral interventions seek to enhance evidence-based health care. However, in case the quality of standard care provided to control conditions varies between studies and affects outcomes, intervention effects cannot be directly interpreted or compared. The objective of the present study was to examine whether standard care quality (SCQ) could be reliably assessed, varies between studies of highly active antiretroviral HIV-adherence interventions, and is related to the proportion of patients achieving an undetectable viral load ("success rate"). Databases were searched for relevant articles. Authors of selected studies retrospectively completed a checklist with standard care activities, which were coded to compute SCQ scores. The relationship between SCQ and the success rates was examined using meta-regression. Cronbach's alpha, variability in SCQ, and relation between SCQ and success rate. Reliability of the SCQ instrument was high (Cronbach's alpha = .91). SCQ scores ranged from 3.7 to 27.8 (total range = 0-30) and were highly predictive of success rate (p = .002). Variation in SCQ provided to control groups may substantially influence effect sizes of behavior change interventions. Future trials should therefore assess and report SCQ, and meta-analyses should control for variability in SCQ, thereby producing more accurate estimates of the effectiveness of behavior change interventions.